Detail
| LncRNA Name | AF113014 |
| Synonyms | NA |
| Region | NA Sequence |
| Ensembl | NA |
| RefSeq | NA |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✔ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 M8170/3 |
| Methods | qPCR, Western blot etc. |
| Sample | liver cancer tissues, cell lines (SMMC7721, HepG2, SK-Hep1 and Huh7) |
| Expression Pattern | differential expression |
| Function Description | AF113014 is differentially expressed between HCC cell lines and normal hepatocytes. Furthermore, we discovered that AF113014 up-regulated Egr2 expression through interacting with miR-20a. |
| Pubmed ID | 28542387 |
| Year | 2017 |
| Title | LncRNA-AF113014 promotes the expression of Egr2 by interaction with miR-20a to inhibit proliferation of hepatocellular carcinoma cells |
| External Links |
| Links for AF113014 | GenBank HGNC lncrnadb Noncode |
| Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.